Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novabay Pharmaceuticals Inc. sell Lokrim

Start price
€13.10
19.01.26 / 20%
Target price
-
19.01.27
Performance (%)
-96.64%
End price
-
11.05.26
Summary
This prediction is currently being closed. Massive losses of -96.64% have been the result for the SELL prediction by Lokrim. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m
Novabay Pharmaceuticals Inc. - -
iShares Core DAX® 2.573% 3.502%
iShares Nasdaq 100 4.858% 0.654%
iShares Nikkei 225® 5.590% -0.246%
iShares S&P 500 3.250% 2.083%

According to Lokrim what are the pros and cons of Novabay Pharmaceuticals Inc. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment
Business model of the past or high risk

Comments by Lokrim for this prediction

In the thread Novabay Pharmaceuticals Inc. diskutieren

Sell Novabay Pharmaceuticals Inc.

In the thread Trading Novabay Pharmaceuticals Inc.
Prediction Sell
Perf. (%) -96.64%
Target price
Change
Ends at 19.01.27

Sell beendet